Growth Kinetics of CD133-positive Prostate Cancer Cells

Prostate - United States
doi 10.1002/pros.22616
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Wiley

Related search

PARP Inhibition Induces Enrichment of DNA Repair Proficient CD133 and CD117 Positive Ovarian Cancer Stem Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Prostate Cancer Promotes Cd11b Positive Cells to Differentiate Into Osteoclasts

Journal of Urology
Urology
2009English

Characterization of the Conversion Between CD133+and CD133-cells in Colon Cancer SW620 Cell Line

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2012English

Therapeutic Targeting of SPINK1-Positive Prostate Cancer

Science Translational Medicine
Medicine
2011English

Delivery of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers for Prostate Cancer

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Effect of CD133 Overexpression on Bone Metastasis in Prostate Cancer Cell Line LNCaP

Oncology Letters
Cancer ResearchOncology
2019English

Involvement of Cyr61 in Growth, Migration, and Metastasis of Prostate Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2008English

Enoxacin Inhibits Growth of Prostate Cancer Cells and Effectively Restores microRNA Processing

Epigenetics
Cancer ResearchMedicineMolecular Biology
2013English

Vascular Endothelial Growth Factor Suppresses Dendritic Cells Function of Human Prostate Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy